Betamethasone / Hydroquinone / Tretinoin Cream

Betamethasone / Hydroquinone / Tretinoin Cream
Usage
Betamethasone, hydroquinone, and tretinoin cream is a compounded topical formulation commonly used for the treatment of melasma, hyperpigmentation, and other pigmentary skin disorders. This combination therapy targets multiple mechanisms involved in skin discoloration, helping to lighten dark patches and improve overall skin tone.
Hydroquinone works by reducing melanin production in the skin, tretinoin promotes increased skin cell turnover and enhances penetration of other active ingredients, and betamethasone helps reduce inflammation and irritation associated with treatment. The combination is often prescribed for moderate to severe melasma or stubborn hyperpigmentation that has not responded adequately to single-agent therapy.

Dosage
This medication is typically compounded as a topical cream for external use.
Common compounded strengths include:
• Hydroquinone: 2–6%
• Tretinoin: 0.025–0.05%
• Betamethasone: 0.05–0.1%
Typical application:
• Apply a thin layer once daily in the evening to affected areas, or as directed by the prescriber.
• The skin should be clean and completely dry before application.
• Avoid contact with the eyes, lips, and mucous membranes.
• Patients should use a broad-spectrum sunscreen (SPF 30 or higher) daily to help prevent recurrence of pigmentation.
Visible improvement is typically observed within 4–8 weeks, although treatment duration may vary depending on the severity of pigmentation.

Mechanisms of Action
Hydroquinone
Hydroquinone inhibits the enzyme tyrosinase, which is essential for melanin production. By reducing melanin synthesis in melanocytes, it helps lighten hyperpigmented areas of the skin.
Tretinoin
Tretinoin is a retinoid (vitamin A derivative) that increases epidermal cell turnover. It promotes the removal of pigmented keratinocytes and enhances penetration of hydroquinone into the skin, improving treatment effectiveness.
Betamethasone
Betamethasone is a topical corticosteroid with anti-inflammatory properties. It reduces redness, irritation, and inflammation associated with tretinoin and hydroquinone therapy, improving tolerability of the treatment.
Together, these agents address melanin production, skin turnover, and inflammation, providing a comprehensive approach to treating hyperpigmentation.

Contraindications & Precautions
Contraindications
• Hypersensitivity to hydroquinone, tretinoin, corticosteroids, or any formulation component
• Pregnancy or women planning pregnancy (due to tretinoin)
• Application to broken, infected, or severely irritated skin
Precautions
• May cause skin irritation, dryness, peeling, redness, or burning, particularly during the initial weeks of treatment.
• Prolonged use of topical corticosteroids may lead to skin thinning, telangiectasia, or steroid-related skin changes.
• Long-term or excessive hydroquinone use may rarely result in exogenous ochronosis, a bluish-black discoloration of the skin.
• Avoid excessive sun exposure, as ultraviolet light may worsen pigmentation or reduce treatment effectiveness.
• Use should generally be limited to affected areas and for the duration recommended by the prescriber.
Patients should discontinue use and seek medical advice if severe irritation, allergic reactions, or worsening skin symptoms occur.